Medicxi Growth I LP 13D/13G Filings for Phathom Pharmaceuticals, Inc. (PHAT)

Medicxi Growth I LP 13D and 13G filings for Phathom Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-01-26
4:00 pm
Purchase		 2024-01-24 13G Phathom Pharmaceuticals, Inc.
PHAT		 Medicxi Growth I LP 7,464,572
13.000%		 4,980,298increase
(+200.47%)		 Filing
2023-01-31
4:00 pm
Purchase		 2022-12-31 13G Phathom Pharmaceuticals, Inc.
PHAT		 Medicxi Growth I LP 2,484,274
6.000%		 416,413increase
(+20.14%)		 Filing